M&A Deal Summary

Unilabs Acquires Alpha medical a.s.

On February 9, 2017, Unilabs acquired life science company Alpha medical a.s. from Mid Europa Partners

Acquisition Highlights
  • This is Unilabs’ 1st transaction in the Life Science sector.
  • This is Unilabs’ 1st transaction in Slovakia.

M&A Deal Summary
Date 2017-02-09
Target Alpha medical a.s.
Sector Life Science
Buyer(s) Unilabs
Sellers(s) Mid Europa Partners
Deal Type Add-on Acquisition

Target

Alpha medical a.s.

Martin, Slovakia
Alpha medical a.s. is a provider of routine and specialised tests, mainly in the areas of biochemistry, microbiology, pathology and genetics, and operates a fully integrated procurement and workflow system.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Unilabs

Geneva, Switzerland
Category Company
Founded 1987
Sector Healthcare Services
Revenue 2.0B EUR (2021)
DESCRIPTION

Unilabs is a European supplier of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies, and the general public. It operates laboratory and medical diagnostic imaging facilities in 15 countries: Czech Republic, Denmark, Finland, France, Italy, KSA, Norway, Peru, Portugal, Slovakia, Spain, Sweden, Switzerland, UAE, and the United Kingdom. Unilabs was founded in 1987 and is based in Geneva, Switzerland.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
Country (Slovakia) 1 of 1
Year (2017) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-19 Centro de Genetica Clinica e Patalogia SA

Porto, Portugal

Centro de Genetica Clinica e Patalogia SA (CGC Genetics) is a provider of genetic testing services to more than 20 countries, including hospitals, national and international, public and private, medical clinics, insurance companies and universities.

Buy -

Seller(S) 1

SELLER

Mid Europa Partners

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 5.3B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Mid Europa Partners is a private equity firm focused on investing in Central and Eastern Europe. Mid Europa prefers control based investments in market leading companies operating in industries with high barriers to entry. Sectors of interest include telecom, media, utilities, transportation, natural resources, industrial, healthcare, building materials, manufacturing, and agriculture. The Firm looks to commit €75 to €200 million of equity capital per transaction in businesses valued up to €500 million. Prospective transaction types include buyouts, take-privates, divestitures, turnarounds, and large scale expansions. Mid Europa Partners is the successor entity to EMP Europe Ltd, which was formed in 1999. Mid Europa has offices in Budapest, Warsaw, and London.

DEAL STATS #
Overall 18 of 28
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 11 of 18
Country (Slovakia) 2 of 2
Year (2017) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-16 Invitel

Budaörs, Hungary

Invitel is an alternative telecommunication service provider, Invitel offers a wide range of info-communication solutions in the whole territory of the country. Invitel was founded in 1992 and is based in Budaors, Hungary.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-21 Zabka Polska

Poznañ, Poland

Zabka Polska is a Polish convenience retailer. The company is among the fastest-growing grocery retail chains in Poland. Żabka has grown from a single convenience store in Poznań to a country wide network of over 5,000 stores. Zabka Polska was founded in 1998 and is based in Poznañ, Poland.

Sell -
Mergr

Product

Company

Legal